Search

Your search keyword '"Loutfy MR"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Loutfy MR" Remove constraint Author: "Loutfy MR" Language english Remove constraint Language: english
157 results on '"Loutfy MR"'

Search Results

1. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies:final results of two randomised, placebo-controlled trials

2. Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

3. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

4. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.

5. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.

6. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study.

9. Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapy.

10. CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.

11. Effects of viral hemorrhagic fever inactivation methods on the performance of rapid diagnostic tests for Plasmodium falciparum.

14. Experiences and resultant care gaps among women with HIV in Canada: concept mapping the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) findings.

15. Piloting an online telecoaching community-based exercise intervention with adults living with HIV: protocol for a mixed-methods implementation science study.

16. Cause-specific mortality among HIV-infected people in Ontario, 1995-2014: a population-based retrospective cohort study.

17. Expert consensus statement on the science of HIV in the context of criminal law.

18. Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada.

19. HIV-related stigma, racial discrimination, and gender discrimination: Pathways to physical and mental health-related quality of life among a national cohort of women living with HIV.

20. Engagement in and continuity of HIV care among African and Caribbean Black women living with HIV in Ontario, Canada.

21. A Structural Equation Model of Factors Contributing to Quality of Life Among African and Caribbean Women Living with HIV in Ontario, Canada.

22. HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada.

23. Lignes directrices canadiennes en matière de planification de la grossesse en présence du VIH.

24. A Structural Equation Model of HIV-Related Stigma, Racial Discrimination, Housing Insecurity and Wellbeing among African and Caribbean Black Women Living with HIV in Ontario, Canada.

25. Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.

26. Emergency department use by people with HIV in Ontario: a population-based cohort study.

27. Comparison of coping strategies and supports between aboriginal and non-aboriginal people living with HIV in Ontario.

28. Gender Differences in Severity and Correlates of Depression Symptoms in People Living with HIV in Ontario, Canada.

29. "Why are you pregnant? What were you thinking?": How women navigate experiences of HIV-related stigma in medical settings during pregnancy and birth.

30. A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection.

31. Maternal placental syndromes among women living with HIV in Ontario: a population-based study.

32. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.

33. Retrospective reports of developmental stressors, syndemics, and their association with sexual risk outcomes among gay men.

34. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.

35. Correlates of a lifetime history of sexually transmitted infections among women who have sex with women in Toronto, Canada: results from a cross-sectional internet-based survey.

36. Adequacy of prenatal care among women living with human immunodeficiency virus: a population-based study.

37. Adverse Neonatal Outcomes Among Women Living With HIV: A Population-Based Study.

39. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells.

40. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction.

41. Recruitment of HIV-Positive Women in Research: Discussing Barriers, Facilitators, and Research Personnel's Knowledge.

42. Examining the Traits-Desires-Intentions-Behavior (TDIB) model for fertility planning in women living with HIV in Ontario, Canada.

43. Trends in live birth rates and adverse neonatal outcomes among HIV-positive women in Ontario, Canada, 2002-2009: a descriptive population-based study.

44. Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential: A Retrospective Study.

45. A group-based HIV and sexually transmitted infections prevention intervention for lesbian, bisexual, queer and other women who have sex with women in Calgary and Toronto, Canada: study protocol for a non-randomised cohort pilot study.

46. Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada.

47. A psycho-educational HIV/STI prevention intervention for internally displaced women in Leogane, Haiti: results from a non-randomized cohort pilot study.

48. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.

49. The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada.

50. Demographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada.

Catalog

Books, media, physical & digital resources